Risk analysis of severe myelotoxicity with temozolomide: The effects of clinical and genetic factors

A benefit of temozolomide (TMZ) is that myelotoxicity is uncommon. Recently, several small series have reported significant myelotoxicity resulting in treatment delays or death. The ability to predict risk of myelotoxicity may influence patient care. We retrospectively reviewed 680 malignant glioma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Armstrong, Terri S., Cao, Yumei, Scheurer, Michael E., Vera-Bolaños, Elizabeth, Manning, Rochelle, Okcu, Mehmet F., Bondy, Melissa, Zhou, Renke, Gilbert, Mark R.
Format: Artigo
Sprog:Inglês
Udgivet: Duke University Press 2009
Fag:
Clinical Investigations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802402/
https://ncbi.nlm.nih.gov/pubmed/19179423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-120
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker